These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034 [TBL] [Abstract][Full Text] [Related]
4. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027 [TBL] [Abstract][Full Text] [Related]
5. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies]. Achury C; Estorch M; Domènech A; Camacho V; Flotats A; Jaller R; Geraldo L; Deportós J; Montes A; Carrió I Rev Esp Med Nucl Imagen Mol; 2014; 33(4):205-9. PubMed ID: 24560597 [TBL] [Abstract][Full Text] [Related]
6. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation. Hagenimana N; Dallaire J; Vallée É; Belzile M J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):22. PubMed ID: 28320460 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT). Familiar C; Merino S; Valhondo R; López C; Pérez X; De Los Monteros PE; Hernández F; Pazos M; Pallarés R; Pascual AC Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):171-178. PubMed ID: 37030900 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results. Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467 [TBL] [Abstract][Full Text] [Related]
10. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET. Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573 [TBL] [Abstract][Full Text] [Related]
11. Focal Thyroid Incidentalomas on de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999 [TBL] [Abstract][Full Text] [Related]
12. The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study: A Systematic Review and Meta-analysis. Nayan S; Ramakrishna J; Gupta MK Otolaryngol Head Neck Surg; 2014 Aug; 151(2):190-200. PubMed ID: 24759908 [TBL] [Abstract][Full Text] [Related]
13. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328 [TBL] [Abstract][Full Text] [Related]
14. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Kim BH; Na MA; Kim IJ; Kim SJ; Kim YK Ann Nucl Med; 2010 Dec; 24(10):721-8. PubMed ID: 20830537 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography. Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940 [TBL] [Abstract][Full Text] [Related]
17. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543 [TBL] [Abstract][Full Text] [Related]
18. Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986 [No Abstract] [Full Text] [Related]
19. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma. Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273 [TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they? Hassan A; Riaz S; Zafar W Nucl Med Commun; 2016 Oct; 37(10):1069-73. PubMed ID: 27571130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]